Abstract:The toxicity of acrylamide (AA) has continuously attracted wide concerns as its extensive presence from both environmental and dietary sources. However, its hepatic metabolic transformation and metabolic fate still remain unclear. This study aims to unravel the metabolic profile and glutathione (GSH) mediated metabolic fate of AA in liver of rats under the dose-dependent exposure. We found that exposure to AA dose-dependently alters the binding of AA and GSH and the generation of mercapturic acid adducts, while liver as a target tissue bears the metabolic transformation of AA via regulating GSH synthesis and consumption pathways, in which glutamine synthase (GSS), cytochrome P450 2E1 (CYP2E1), and glutathione S-transferase P1 (GSTP1) play a key role. In response to high- and low-dose exposures to AA, there were significant differences in liver of rats, including the changes in GSH and cysteine (CYS) activities and the conversion ratio of AA to glycidamide (GA), and liver can affect the transformation of AA by regulating the GSH-mediated metabolic pathway. Low-dose exposure to AA activates GSH synthesis pathway in liver and upregulates GSS activity and CYS content with no change in γ-glutamyl transpeptidase 1 (GGT1) activity. High-dose exposure to AA activates the detoxification pathway of GSH and increases GSH consumption by upregulating GSTP1 activity. In addition, molecular docking results showed that most of the metabolic molecules transformed by AA and GA other than themselves can closely bind to GSTP1, GSS, GGT1, N-acetyltransferase 8, and dimethyl sulfide dehydrogenase 1. The binding of AA-GSH and GA-GSH to GSTP1 and CYP2E1 enzymes determine the tendentiousness between toxicity and detoxification of AA, which exerts a prospective avenue for targeting protective role of hepatic enzymes against in vivo toxicity of AA.

Mitochondrial dysfunction and underlying molecular mechanisms in acrylamide-induced toxicity

Acrylamide Induces Abnormal Mtdna Expression by Causing Mitochondrial ROS Accumulation, Biogenesis, and Dynamics Disorders.

Unraveling the Serum Metabolomic Profile of Acrylamide-Induced Cardiovascular Toxicity

Acrylamide-Induced Hepatotoxicity Through Oxidative Stress: Mechanisms and Interventions

Advanced Research on Metabolic Mechanism and Toxicity Protection of Acrylamide:in Vivo

Mitochondrion-Mediated Apoptosis Induced by Acrylamide is Regulated by a Balance Between Nrf2 Antioxidant and MAPK Signaling Pathways in PC12 Cells

The Mechanism of Acrylamide-Induced Neurotoxicity: Current Status and Future Perspectives

Mechanistic progression of acrylamide neurotoxicity linked to neurodegeneration and mitigation strategies

Relationship between antioxidants and acrylamide formation: A review

Acrylamide-induced Neurotoxicity in Primary Astrocytes and Microglia: Roles of the Nrf2-ARE and NF-κB Pathways

Characterization of Acrylamide-Induced Oxidative Stress and Cardiovascular Toxicity in Zebrafish Embryos.

Effect of acrylamide-induced neurotoxicity in a primary astrocytes/microglial co-culture model.

Research progress in biomarker analysis and risk assessment of acrylamide exposure in vivo

MiR-27a-5p Regulates Acrylamide-Induced Mitochondrial Dysfunction and Intrinsic Apoptosis Via Targeting Btf3 in Rats

Research progress on the toxicity of acrylamide

Acrylamide Induces Mitochondrial Dysfunction and Apoptosis in BV-2 Microglial Cells.

The Involvement of Oxidative Stress, Neuronal Lesions, Neurotransmission Impairment, and Neuroinflammation in Acrylamide-Induced Neurotoxicity in C57/BL6 Mice.

Metabolism of Acrylamide: Interindividual and Interspecies Differences As Well As the Application As Biomarkers

Acrylamide Induces Mitophagy and Alters Macrophage Phenotype via Reactive Oxygen Species Generation

Reconstructing hepatic metabolic profile and glutathione-mediated metabolic fate of acrylamide

Research progress on metabolism and toxicology of acrylamide